These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11099889)

  • 1. Treatment of schizoaffective disorder with divalproex sodium.
    DelBello MP; Lopez-Larson MP; Getz GE; Strakowski SM
    Schizophr Res; 2000 Nov; 46(1):77-9. PubMed ID: 11099889
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
    Minirth FB; Neal V
    J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
    Centorrino F; Kelleher JP; Berry JM; Salvatore P; Eakin M; Fogarty KV; Fellman V; Baldessarini RJ
    Am J Psychiatry; 2003 Jul; 160(7):1348-50. PubMed ID: 12832255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalproex versus valproate in patients with bipolar disorder.
    Kablinger AS; Czerwinski WP; Minagar A
    J Clin Psychopharmacol; 2004 Apr; 24(2):231-2. PubMed ID: 15206673
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose lithium augmentation of divalproex in geriatric mania.
    Goldberg JF; Sacks MH; Kocsis JH
    J Clin Psychiatry; 2000 Apr; 61(4):304. PubMed ID: 10830157
    [No Abstract]   [Full Text] [Related]  

  • 8. Agitated symptom response to divalproex following acute brain injury.
    Chatham Showalter PE; Kimmel DN
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):395-7. PubMed ID: 10956575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Olson DA; Ingram W; Mann JR
    J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic treatment of patients hospitalized with the diagnosis of schizoaffective disorder.
    Grieger TA; Benedek DM; Flynn J
    J Clin Psychiatry; 2001 Jan; 62(1):59-60. PubMed ID: 11235933
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of divalproex therapy for schizoaffective disorder.
    Bogan AM; Brown ES; Suppes T
    J Clin Psychopharmacol; 2000 Oct; 20(5):520-2. PubMed ID: 11001235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium in sex offenders with bipolar disorders and comorbid paraphilias: an open retrospective study.
    Nelson E; Brusman L; Holcomb J; Soutullo C; Beckman D; Welge JA; Kuppili N; McElroy SL
    J Affect Disord; 2001 May; 64(2-3):249-55. PubMed ID: 11313091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate and neuroleptic medication.
    Reutens S; Castle D
    Br J Psychiatry; 1997 May; 170():484-5. PubMed ID: 9307707
    [No Abstract]   [Full Text] [Related]  

  • 15. Divalproex sodium as a treatment for borderline personality disorder.
    Wilcox JA
    Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intravenous valproate in acute mania.
    Norton JW
    Gen Hosp Psychiatry; 2000; 22(5):389-91. PubMed ID: 11203036
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended-release divalproex sodium for mood stabilization.
    Stoner SC; Dubisar BM; Lea JW; Marken PA; Ramlatchman LV; Reynolds JB
    Pharmacotherapy; 2004 Sep; 24(9):1147-53. PubMed ID: 15460175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone as an adjunct to valproic acid.
    Waring EW; Dewan VK; Cohen D; Grewal R
    Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous valproate treatment: some observations.
    Duggal HS
    Can J Psychiatry; 2002 Feb; 47(1):96. PubMed ID: 11873717
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL; Cunanan C
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.